Ostatní
Návod 
BridgeBio Pharma, Inc.
BBIO
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
12.0B
Obrat
1B
Zisk
-1B
Aktiva
1B
Dluh
0B
ROE
41%
ROA
-80%
PE
-19
PS
27
Cena 1R
28-80
⌀ Cena
51.91
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
27-04-2026
Poslední dividenda
Profil
Společnost BridgeBio Pharma, Inc. se zabývá objevováním, vývojem a distribucí různých léků na genetická onemocnění. Společnost má připraveno 30 vývojových programů, které zahrnují produktové kandidáty od raného objevování až po pozdní fázi vývoje. Jeho produkty ve vývojových programech zahrnují AG10 a BBP-265, malý molekulový stabilizátor transthyretinu, nebo TTR, který je ve fázi 3 klinické studie pro léčbu TTR amyloidózy-kardiomyopatie, nebo ATTR-CM; BBP-831, malý molekulární selektivní inhibitor FGFR1-3, což je fáze 2 klinické studie pro léčbu achondroplazie u pediatrických pacientů; a BBP-631, kandidát na genový přenos AV5, který je ve fázi 2 klinické studie pro léčbu konjunktury hyperplazie genitálu nadledvin nebo CAH vyvolaná deficitem 21-hydroxylázy neboli 21OHD. Společnost také vyvíjí Encaleret, což je malý molekulární antagonista receptoru pro snímání kalcia, nebo CaSR, který je ve fázi 2 klinické studie pro prokázání konceptu autozomálně dominantní hypokalcémie typu 1 nebo ADH1; a BBP-711 pro léčbu hyperoxalurie, stejně jako pacienti trpící opakujícími se ledvinovými kameny. Kromě toho se zabývá vývojem produktů pro nemoci mendelovské, onkologické a genové terapie. BridgeBio Pharma, Inc. má licenční a kolaborační smlouvy s Leland Stanford Junior University a The Regents of the University of California; Leidos Biomedical Research, Inc. Společnost byla založena v roce 2015 a sídlí v Palo Alto v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
725
Založení
2019-06-27
Podobné společnosti
$ 62.37
+ $ 1.36
$ 69.82
- $ 3.73
$ 198.90
+ $ 1.16
$ 17.99
- $ 0.20
$ 20.80
+ $ 0.18
$ 23.89
- $ 0.66
$ 52.17
+ $ 0.71
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 502.1 | 502.1 | 221.9 | 9.3 | 77.6 | 69.7 | 8.2 | 40.6 | 0.0 | 0.0 | |
| Cost of Revenues | 28.3 | 28.3 | 3.9 | 2.4 | 3.4 | 3.1 | 0.0 | 2.5 | 0.0 | 0.0 | |
| Gross Profit | 473.8 | 473.8 | 218.0 | 6.9 | 74.2 | 66.6 | 8.2 | 38.1 | 0.0 | 0.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 154.2 | 120.7 | 110.6 | 116.6 | 5.9 | 2.7 | 2.2 | 211.1 | 1.7 | 4.1 | |
| Cost of Revenues | 15.4 | 6.6 | 3.7 | 2.6 | 2.1 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | |
| Gross Profit | 138.8 | 114.1 | 106.9 | 114.0 | 3.8 | 2.1 | 1.6 | 210.5 | 1.1 | 3.5 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 455.7 | 402.9 | 454.1 | 337.0 | 209.9 | 140.1 | 30.6 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 150.6 | 143.2 | 192.2 | 145.7 | 94.4 | 43.6 | 13.3 | |
| Depreciation & Amortization | 9.0 | 9.0 | 6.1 | 6.5 | 118.2 | 40.1 | 5.6 | -13.2 | 0.2 | 0.3 | |
| Total Operating Expenses | 1,042.9 | 1,042.9 | 811.0 | 614.2 | 546.1 | 646.3 | 482.7 | 304.3 | 183.7 | 43.9 | |
| Operating Income | -569.1 | -569.1 | -593.0 | -607.4 | -471.9 | -579.7 | -474.5 | -266.2 | -183.7 | -43.9 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 130.2 | 125.1 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 47.6 | 35.8 | ||
| Depreciation & Amortization | 5.0 | 1.4 | 1.3 | 1.3 | 1.4 | 1.5 | 1.6 | 1.6 | 1.6 | 1.6 | ||
| Total Operating Expenses | 324.0 | 259.3 | 241.2 | 218.4 | 229.8 | 193.9 | 177.1 | 210.2 | 177.8 | 161.2 | ||
| Operating Income | -185.2 | -145.2 | -134.3 | -104.4 | -226.0 | -191.8 | -175.5 | 0.3 | -177.4 | -157.7 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 19.9 | 19.9 | 17.2 | 18.0 | 7.5 | 1.1 | 4.0 | 8.9 | 2.0 | 0.0 | |
| Interest Expense | 103.5 | 53.1 | 99.3 | 81.3 | 80.4 | 46.8 | 36.7 | 8.8 | 2.5 | 0.0 | |
| Other Expense | -165.9 | -165.9 | 50.8 | -45.9 | -12.8 | -6.7 | -31.0 | -22.3 | 14.8 | 0.0 | |
| IBT | -735.0 | -735.0 | -542.2 | -653.3 | -484.7 | -586.5 | -505.5 | -288.6 | -169.5 | -43.8 | |
| Income Tax Expense | 0.6 | 0.6 | 1.2 | 0.0 | 9.3 | 52.8 | -21.6 | -28.1 | 16.8 | -13.5 | |
| Net Income | -729.3 | -729.3 | -535.8 | -643.2 | -494.0 | -639.3 | -483.9 | -260.4 | -130.7 | -30.6 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 4.3 | 6.2 | 3.9 | 5.4 | 4.7 | 3.3 | 5.2 | 4.1 | 5.6 | 3.8 | ||
| Interest Expense | 12.0 | 11.7 | 37.6 | 42.1 | 29.8 | 23.1 | 22.9 | 23.5 | 20.3 | 20.3 | ||
| Other Expense | -12.0 | -41.3 | -47.4 | -65.2 | -40.2 | 27.5 | 100.0 | -36.5 | 7.1 | -21.8 | ||
| IBT | -197.2 | -186.5 | -181.7 | -169.6 | -266.2 | -164.3 | -75.5 | -36.2 | -170.3 | -177.0 | ||
| Income Tax Expense | 0.0 | -1.5 | 2.1 | 0.0 | 1.2 | 0.0 | 0.0 | 0.0 | 18.4 | -1.6 | ||
| Net Income | -197.2 | -182.7 | -181.9 | -167.4 | -265.1 | -162.0 | -73.5 | -35.2 | -168.1 | -177.0 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-3.95 | $-3.35 | $-4.43 | $-4.10 | $-2.48 | $-1.42 | $-0.33 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-3.95 | $-3.35 | $-4.43 | $-4.10 | $-2.48 | $-1.42 | $-0.33 | |
| Shares Outstanding | 197.2 | 197.2 | 186.1 | 162.8 | 147.5 | 144.4 | 118.0 | 105.1 | 92.3 | 92.3 | |
| Diluted Shares Outstanding | 197.2 | 197.2 | 186.1 | 162.8 | 147.5 | 144.4 | 118.0 | 105.1 | 92.3 | 92.3 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.96 | $-1.08 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.96 | $-1.08 | ||
| Shares Outstanding | 197.2 | 190.5 | 190.5 | 190.1 | 189.4 | 188.5 | 187.6 | 178.7 | 174.5 | 163.3 | ||
| Diluted Shares Outstanding | 197.2 | 190.5 | 190.5 | 190.1 | 189.4 | 188.5 | 187.6 | 178.7 | 174.5 | 163.3 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 547.4 | 681.1 | 375.9 | 376.7 | 393.8 | 356.1 | 363.8 | 436.1 | 92.0 | |
| Short Term Investments | 39.8 | 0.0 | 58.9 | 95.2 | 442.9 | 251.0 | 182.2 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 587.2 | 681.1 | 434.9 | 428.3 | 787.5 | 607.1 | 577.1 | 436.1 | 92.0 | |
| Accounts Receivable | 0.7 | 4.7 | 1.8 | 17.1 | 19.7 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Inventory | 0.0 | 0.0 | 0.0 | 37.9 | -68.9 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 28.4 | 34.9 | 41.0 | 21.9 | 101.3 | 35.7 | 22.6 | 2.1 | 0.9 | |
| Total Current Assets | 616.2 | 720.7 | 477.6 | 505.2 | 839.7 | 642.8 | 599.8 | 445.2 | 97.1 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 643.0 | 749.4 | 540.6 | 681.1 | 266.3 | 547.4 | 475.4 | 375.9 | 505.2 | 302.4 | |
| Short Term Investments | 3.0 | 7.9 | 0.0 | 0.0 | 0.0 | 39.8 | 44.5 | 58.9 | 38.1 | 333.3 | |
| Total Cash & ST Investments | 645.9 | 757.3 | 540.6 | 681.1 | 266.3 | 587.2 | 519.8 | 434.9 | 505.2 | 333.3 | |
| Accounts Receivable | 116.5 | 76.9 | 115.3 | 4.7 | 0.5 | 0.7 | 235.5 | 1.8 | 5.2 | 8.6 | |
| Inventory | 24.5 | 18.3 | 4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 16.7 | 16.7 | 19.9 | |
| Other Current Assets | 52.4 | 59.8 | 35.4 | 34.9 | 177.8 | 28.4 | 28.2 | 41.0 | 39.2 | 40.5 | |
| Total Current Assets | 839.4 | 912.3 | 695.2 | 720.7 | 444.6 | 616.2 | 783.4 | 477.6 | 549.6 | 382.4 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 17.1 | 12.8 | 19.8 | 25.2 | 46.0 | 36.8 | 5.6 | 1.6 | 0.4 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 25.1 | 23.9 | 26.3 | 28.7 | 44.9 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 119.1 | 143.7 | 0.0 | 43.7 | 49.1 | 0.0 | 31.1 | 17.1 | 0.0 | |
| Other Long-Term Assets | 16.8 | 18.2 | 22.6 | 20.2 | 33.0 | 23.9 | -4.9 | 1.1 | 0.5 | |
| Total Long-Term Assets | 178.1 | 198.6 | 68.8 | 117.8 | 173.1 | 60.8 | 31.9 | 19.7 | 0.9 | |
| Total Assets | 794.4 | 919.3 | 546.4 | 623.0 | 1,012.8 | 703.6 | 631.7 | 464.9 | 98.0 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 12.4 | 12.3 | 13.9 | 12.8 | 15.1 | 17.1 | 19.5 | 19.8 | 21.7 | 22.9 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 28.8 | 29.5 | 27.8 | 23.9 | 24.5 | 25.1 | 25.7 | 26.3 | 26.9 | 27.5 | |
| Long-Term Investments | 0.0 | 109.7 | 128.2 | 143.7 | 160.4 | 119.1 | 3.9 | 3.7 | 38.1 | 50.5 | |
| Other Long-Term Assets | 117.7 | 16.4 | 16.6 | 18.2 | 20.3 | 16.8 | 16.8 | 22.6 | 18.7 | 20.4 | |
| Total Long-Term Assets | 158.9 | 167.9 | 186.5 | 198.6 | 220.4 | 178.1 | 65.9 | 68.8 | 105.4 | 121.3 | |
| Total Assets | 998.3 | 1,080.2 | 881.6 | 919.3 | 665.0 | 794.4 | 849.3 | 546.4 | 655.0 | 503.7 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 18.1 | 9.6 | 10.7 | 11.6 | 11.9 | 8.9 | 8.9 | 13.5 | 1.9 | |
| Short-Term Debt | 4.6 | 4.5 | 8.3 | 3.7 | 4.9 | 1.5 | 8.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 96.5 | 140.3 | 118.8 | 94.4 | 113.3 | 5.6 | 4.1 | 19.1 | 6.7 | |
| Current Liabilities | 134.4 | 154.4 | 143.8 | 117.8 | 130.1 | 91.9 | 52.4 | 32.6 | 8.6 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 18.7 | 26.1 | 27.5 | 9.6 | 13.4 | 18.1 | 4.7 | 10.7 | 4.5 | 3.9 | |
| Short-Term Debt | 5.3 | 14.4 | 5.2 | 4.5 | 4.6 | 4.6 | 9.1 | 8.3 | 4.1 | 7.6 | |
| Other Current Liabilities | 183.5 | 124.8 | 119.4 | 140.3 | 109.5 | 96.5 | 113.7 | 118.8 | 90.9 | 92.5 | |
| Current Liabilities | 216.6 | 175.9 | 152.1 | 154.4 | 139.2 | 134.4 | 141.5 | 143.8 | 101.9 | 106.3 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 1,717.6 | 1,726.1 | 1,735.7 | 1,723.6 | 1,726.2 | 494.3 | 99.8 | 54.5 | 0.0 | |
| Capital Leases | 7.1 | 9.2 | 13.1 | 15.9 | 22.4 | 18.5 | 8.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 7.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 1,876.5 | 2,377.0 | 1,888.9 | 1,868.0 | 1,878.4 | 595.7 | 155.7 | 566.4 | 152.7 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 3.4 | 2,667.5 | 1,853.0 | 1,726.1 | 1,725.1 | 1,724.7 | 1,724.2 | 1,735.7 | 1,730.9 | 1,729.9 | |
| Capital Leases | 8.7 | 8.8 | 10.1 | 9.2 | 10.4 | 7.1 | 8.3 | 13.1 | 13.9 | 14.7 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.3 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 2,921.0 | 2,858.6 | 2,520.3 | 2,377.0 | 1,883.4 | 1,876.5 | 1,886.2 | 1,888.9 | 1,848.7 | 1,853.3 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 6.6 | 3.4 | |
| Retained Earnings | -2,669.2 | -3,096.3 | -2,560.5 | -1,918.1 | -1,437.0 | -888.8 | -440.0 | -170.6 | -61.4 | |
| Comprehensive Income | 0.0 | 0.0 | 0.0 | -0.3 | -0.1 | 0.2 | 0.3 | -0.2 | 0.0 | |
| Total Common Equity | -1,092.9 | -1,467.9 | -1,354.3 | -1,254.6 | -870.4 | 57.9 | 408.5 | -164.0 | -58.0 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |
| Retained Earnings | -3,628.3 | -3,445.6 | -3,263.7 | -3,096.3 | -2,831.2 | -2,669.2 | -2,595.7 | -2,560.5 | -2,392.4 | -2,215.4 | |
| Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| Total Common Equity | -1,922.7 | -1,787.9 | -1,648.4 | -1,467.9 | -1,229.9 | -1,092.9 | -1,049.5 | -1,354.3 | -1,207.5 | -1,362.0 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 1,729.3 | 1,730.6 | 1,739.8 | 1,723.6 | 1,726.2 | 495.8 | 99.8 | 54.5 | 0.0 | |
| Book Value | -1,082.1 | -1,457.6 | -1,342.5 | -1,244.9 | -865.6 | 107.9 | 476.0 | -101.5 | -54.7 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 9.4 | 9.7 | 10.3 | 11.5 | 10.8 | 12.7 | 11.7 | 13.8 | 12.4 | |
| Book Value | -1,922.7 | -1,787.9 | -1,648.4 | -1,467.9 | -1,229.9 | -1,092.9 | -1,049.5 | -1,354.3 | -1,207.5 | -1,362.0 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -458.5 | -724.9 | -543.3 | -643.2 | -484.7 | -586.5 | -505.5 | -288.6 | -169.5 | -43.8 | |
| Depreciation & Amortization | 6.4 | 6.0 | 6.1 | 6.5 | 6.8 | 5.8 | 3.1 | 0.0 | 0.2 | 0.3 | |
| Stock-Based Compensation | 98.1 | 133.0 | 95.8 | 0.0 | 91.6 | 99.5 | 58.5 | 21.4 | 6.1 | 1.8 | |
| Change Working Capital | 44.5 | -51.1 | 32.0 | 5.1 | 28.1 | -4.4 | 14.9 | -10.9 | 22.5 | 1.2 | |
| Change In Accounts Receivable | 8.0 | -134.7 | -3.0 | 15.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | 15.7 | 26.6 | 1.5 | 2.8 | -0.3 | 2.8 | -0.7 | -4.7 | 16.7 | 1.6 | |
| Change In Inventories | -6.9 | -25.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | -53.9 | 191.1 | -111.3 | 103.9 | -61.3 | 18.5 | 31.2 | 24.5 | 18.9 | 0.3 | |
| Cash from Operations | -414.9 | 0.0 | 0.0 | -527.7 | -419.5 | -497.9 | -399.7 | -253.6 | -136.6 | -40.5 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -190.3 | -182.7 | -183.8 | -169.6 | -267.4 | -164.3 | -73.5 | -36.2 | -170.3 | -179.5 | |
| Depreciation & Amortization | 1.5 | 1.4 | 1.3 | 1.3 | 1.4 | 1.5 | 1.6 | 1.6 | 1.6 | 1.6 | |
| Stock-Based Compensation | 34.6 | 0.0 | 37.2 | 25.9 | 30.1 | 27.2 | 21.5 | 17.1 | 37.0 | 22.6 | |
| Change Working Capital | 49.6 | -3.9 | 19.4 | -116.2 | 12.9 | -2.1 | 246.4 | -225.2 | 22.0 | 1.3 | |
| Change In Accounts Receivable | -22.9 | -39.7 | 38.4 | -110.5 | -4.2 | 0.2 | 234.8 | -233.7 | 3.4 | 3.4 | |
| Change In Accounts Payable | 17.5 | -7.4 | -1.1 | 17.6 | -3.7 | -3.6 | 14.8 | -5.9 | 6.2 | 0.7 | |
| Change In Inventories | -2.0 | -6.8 | -13.4 | -3.2 | 0.0 | 0.0 | 0.0 | 0.0 | -3.4 | -3.4 | |
| Other Non-cash Items | 48.1 | 75.7 | 45.1 | 59.4 | 27.6 | -42.9 | -121.3 | 23.2 | 7.2 | 3.1 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -124.8 | -145.2 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -4.8 | -1.1 | -0.9 | -1.3 | -6.3 | -48.2 | -7.5 | -5.1 | -18.2 | -0.5 | |
| Acquisitions | -38.6 | 0.0 | -0.1 | 0.0 | 0.0 | -35.0 | 0.0 | 0.0 | -2.9 | 0.0 | |
| Investments | -160.1 | -28.2 | -88.4 | -137.3 | -193.1 | -643.3 | -287.9 | -212.9 | 0.0 | 0.0 | |
| Sales of Investment | 202.7 | 11.0 | 158.2 | 193.1 | 532.5 | 477.0 | 242.2 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 64.1 | 0.0 | 0.0 | -0.5 | 120.0 | 48.7 | 0.1 | 0.8 | 0.0 | 0.0 | |
| Cash from Investing | 63.4 | 0.0 | 0.0 | 54.0 | 453.1 | -200.8 | -53.0 | -217.3 | -21.0 | -0.5 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.0 | -2.9 | -0.6 | -1.6 | 0.0 | -0.1 | -0.1 | -0.7 | -0.4 | -0.4 | |
| Acquisitions | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | -0.4 | -38.1 | |
| Investments | -17.3 | -3.0 | -7.9 | 0.0 | 0.0 | 0.0 | -49.4 | -64.7 | -29.2 | -16.8 | |
| Sales of Investment | 3.0 | 8.0 | 0.0 | 0.0 | 0.0 | 40.0 | 55.0 | 63.2 | 29.6 | 54.9 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 38.1 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 37.7 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -39.4 | 0.0 | 0.0 | 0.0 | -20.5 | -124.1 | 0.0 | 0.0 | -1.1 | 0.0 | |
| Debt Issued | 35.1 | 1,730.6 | -9.3 | 16.3 | 17.9 | 1,354.5 | 396.0 | 45.3 | 55.6 | 0.0 | |
| Issuance of Common Stock | 630.9 | 0.0 | 0.0 | 449.8 | 4.9 | 3.8 | 1.2 | 366.2 | 95.5 | 0.0 | |
| Repurchase of Common Stock | -9.8 | -48.3 | -7.5 | -6.9 | -1.6 | -204.7 | -75.7 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.8 | 0.0 | -1.0 | 0.0 | -1.2 | |
| Other Financing Activities | 291.7 | 0.0 | 0.0 | 8.6 | 4.1 | 1,065.3 | 521.7 | 33.6 | 407.1 | 114.1 | |
| Cash from Financing | 576.3 | 0.0 | 0.0 | 451.5 | -13.1 | 736.4 | 447.2 | 398.8 | 501.5 | 113.0 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 8.7 | -2,668.4 | 818.9 | 127.7 | 0.8 | 0.5 | 0.5 | -11.1 | 4.8 | 1.4 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.5 | 306.2 | |
| Repurchase of Common Stock | 0.0 | 0.0 | -2.0 | -50.1 | -1.4 | -1.4 | -1.7 | -2.9 | -2.6 | -2.6 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.0 | 3.4 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.5 | 307.0 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 224.9 | -111.1 | 288.5 | -22.2 | 20.5 | 37.7 | -5.5 | -72.0 | 343.9 | 72.0 | |
| Closing Cash Balance | 547.4 | 572.1 | 683.2 | 394.7 | 416.9 | 396.4 | 358.7 | 364.2 | 436.2 | 92.4 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -72.4 | -106.3 | 208.4 | -140.5 | 275.4 | -141.6 | 72.0 | 82.8 | -129.4 | 199.5 | |
| Closing Cash Balance | 572.1 | 643.1 | 751.1 | 542.7 | 683.2 | 407.9 | 547.4 | 477.5 | 394.7 | 524.1 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -419.7 | -447.0 | -521.7 | -529.0 | -425.8 | -546.2 | -407.2 | -258.7 | -154.8 | -41.0 | |
| Real Free Cash Flow | -517.8 | -580.0 | -617.5 | -529.0 | -517.4 | -645.7 | -465.7 | -280.1 | -160.9 | -42.8 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -61.0 | -110.0 | -85.8 | -200.8 | -198.6 | -182.3 | 72.3 | -221.0 | -125.3 | -145.7 | |
| Real Free Cash Flow | -95.6 | -110.0 | -123.0 | -226.7 | -228.7 | -209.5 | 50.8 | -238.1 | -162.3 | -168.3 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -18.5 | -10.5 | -1.4 |
| P/S | 26.9 | 160 | 9.4 |
| P/B | -7 | 0.9 | 5.2 |
| P/FCF | -24.3 | -9.9 | -1.5 |
| Market cap | $12.0 | $7.1 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0.9 % | 134.2 % | 0 % |
| Debt to Income | -1.2 % | -197.4 % | 0 % |
| Debt to Free cash flow | -1.6 % | -528.3 % | 0 % |
| Interest expense percentage | -18.2 % | -9.5 % | 44.7 % |
| Current ratio | 3.9 | 6.9 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 37.9 % | -7 % | 0 % |
| ROA | -73.1 % | -57.4 % | 0 % |
| CapEx to Revenue | 1.4 % | 20.2 % | 0 % |
| RaD to Revenue | 0 % | 1121.4 % | 0 % |
| ROEM | 692,521.4 | 44815.8 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 95.8 % | 75 % | 68.7 % |
| Operating margin | -172.4 % | -1482.9 % | 35.5 % |
| Net margin | -225.3 % | -1601.2 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0.8 % | 0 % |
| Dividend payout percentage | 0 % | -2.7 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 190.5 mil | 142.7 mil |
| Employee count | 0.7 tis | 12.9 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
